Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 209406
Company: WATSON LABS INC
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
BRINZOLAMIDE BRINZOLAMIDE 1% SUSPENSION/DROPS;OPHTHALMIC Prescription AB No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
11/27/2020 ORIG-1 Approval STANDARD Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/209406Orig1s000ltr.pdf

BRINZOLAMIDE

SUSPENSION/DROPS;OPHTHALMIC; 1%
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
AZOPT BRINZOLAMIDE 1% SUSPENSION/DROPS;OPHTHALMIC Prescription Yes AB 020816 NOVARTIS
BRINZOLAMIDE BRINZOLAMIDE 1% SUSPENSION/DROPS;OPHTHALMIC Prescription No AB 204884 BAUSCH
BRINZOLAMIDE BRINZOLAMIDE 1% SUSPENSION/DROPS;OPHTHALMIC Prescription No AB 209406 WATSON LABS INC

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English